A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Clinical trial NCT06056297 · RECRUITING
Trial details
- NCT number
- NCT06056297
- Sponsor
- X4 Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-06
- Primary completion
- 2027-09-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.